Zhuling Jianpi Capsule

Under conditions of widespread clinical use, a Phase IV clinical trial was conducted to further evaluate the safety and effectiveness of Shuling Jianpi Capsule in the treatment of diarrhea-predominant irritable bowel syndrome (spleen and kidney qi deficiency with qi stagnation and damp-heat syndrome), with a focus on observing possible adverse reactions, including the type of adverse reactions, the incidence of adverse reactions, and the clinical manifestations and severity of adverse reactions.